205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
5.20%
Revenue growth 50-75% of MCHP's 8.12%. Martin Whitman would scrutinize if slower growth is temporary.
10.72%
Cost growth above 1.5x MCHP's 3.65%. Michael Burry would check for structural cost disadvantages.
-6.44%
Gross profit decline while MCHP shows 11.15% growth. Joel Greenblatt would examine competitive position.
-11.06%
Margin decline while MCHP shows 2.80% expansion. Joel Greenblatt would examine competitive position.
-100.00%
R&D reduction while MCHP shows 15.69% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.46%
Operating expenses reduction while MCHP shows 11.40% growth. Joel Greenblatt would examine advantage.
6.89%
Similar total costs growth to MCHP's 7.28%. Walter Schloss would investigate norms.
No Data
No Data available this quarter, please select a different quarter.
-416.67%
D&A reduction while MCHP shows 22.73% growth. Joel Greenblatt would examine efficiency.
-12.30%
EBITDA decline while MCHP shows 13.79% growth. Joel Greenblatt would examine position.
-16.63%
EBITDA margin decline while MCHP shows 5.25% growth. Joel Greenblatt would examine position.
-6.41%
Operating income decline while MCHP shows 10.77% growth. Joel Greenblatt would examine position.
-11.03%
Operating margin decline while MCHP shows 2.45% growth. Joel Greenblatt would examine position.
450.00%
Other expenses growth above 1.5x MCHP's 150.00%. Michael Burry would check for concerning trends.
-0.23%
Pre-tax income decline while MCHP shows 13.28% growth. Joel Greenblatt would examine position.
-5.16%
Pre-tax margin decline while MCHP shows 4.78% growth. Joel Greenblatt would examine position.
-2.11%
Tax expense reduction while MCHP shows 8.82% growth. Joel Greenblatt would examine advantage.
0.69%
Net income growth below 50% of MCHP's 14.89%. Michael Burry would check for structural issues.
-4.28%
Net margin decline while MCHP shows 6.27% growth. Joel Greenblatt would examine position.
-5.26%
EPS decline while MCHP shows 14.98% growth. Joel Greenblatt would examine position.
-5.26%
Diluted EPS decline while MCHP shows 14.98% growth. Joel Greenblatt would examine position.
0.57%
Share count change of 0.57% while MCHP is stable. Bruce Berkowitz would verify approach.
-0.27%
Diluted share reduction while MCHP shows 0.00% change. Joel Greenblatt would examine strategy.